Antimicrobial resistance (AMR) is a global health security threat. Our AMR response focuses on strengthening public health systems in our region.
Antimicrobial resistance (AMR) is a global health security threat, complicating efforts to fight diseases like HIV, malaria and tuberculosis. Microbes that have developed medicine resistance (‘superbugs’) cause drug-resistant infections contributing to nearly 5 million deaths annually. Our AMR response focuses on strengthening public health systems in our region.
Our aim is to improve our region’s response to the growing global health security threat of antimicrobial resistance. We work with governments, national AMR committees and public health counterparts across the region, supporting national AMR action plans and priorities.
Our work contains four key themes.
Through training and mentoring, we establish relevant policies and procedures for monitoring selected healthcare-associated infections.
We train and mentor in stewardship for monitoring antibiotic use, managing antimicrobial stewardship and responding to emerging issues.
We offer training, mentoring and support to:
We embrace a One Health approach. This recognises that the health of people is closely connected to the health of animals and our shared environment.
We therefore conduct cross-sectoral surveillance of AMR and antimicrobial use across human and animal health.
We're working with partners to see how the 7-1-7 approach can help track and respond to disease outbreaks in the Pacific.
By 2050, antimicrobial resistant bacteria (AMR) could cause 10 million deaths annually. Our collaborative project supports Papua New Guinea’s domestic AMR response.
Burnet Institute is leading the Papua New Guinea Country Grant component of the Fleming Fund, a UK Aid program tackling antimicrobial resistance in low- and middle-income countries.